"The Impact of Anaemia and its Treatment on Employee Disability and Medical Costs."

Berndt, Ernst R., William H. Crown, Joel D. Kallich, Stacey R. Long, Xue Song and Gary H. Lyman. PharmacoEconomics Vol. 23, No. 2 (2005): 183-192.

"To Inform or Persuade? Direct-to-Consumer Advertising of Prescription Drugs."

Berndt, Ernst R. New England Journal of Medicine Vol. 352, No. 4 (2005): 325-328.

"Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process."

Berndt, Ernst R., Adrian H. B. Gottschalk, Tomas Philipson and Matthew W. Strobeck. In Forum for Health Economics and Policy, edited by Alan M. Garber and David M. Cutler, Berlin, Germany: De Gruyter, 2005.

"Performance Decrements Resulting from Illness in the Workplace: The Effect of Headaches."

Pransky, Glenn S., Ernst R. Berndt, Stanley N. Finkelstein, S. Verma and Ashwini Agrawal. Journal of Occupational and Environmental Medicine Vol. 47, No. 1 (2005): 34-40.

"Economic Impacts of Anxiety Disorders: A Review."

Berndt, Ernst R. and Tamar Sisitsky. Mental Fitness: The Science of Mental Wellness, December 2004.

"Effects of Pharmaceutical Promotion on Adherence to Guideline Treatment of Depression."

Donohue, Julie M., Ernst R. Berndt, Meredith Rosenthal, Arnold M. Epstein and Richard G. Frank. Medical Care Vol. 42, No. 12 (2004): 1176-1185.